Stay updated on Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now includes a 2019 U.S. NIH grant/contract acknowledgment and adds a publication citation about the overall survival findings related to EV-302. These additions provide background references and funding context for the study.
    Difference
    0.0%
    Check dated 2026-08-27T17:47:16.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.5, replacing the previous v3.6.4, signaling a software update.
    Difference
    0.0%
    Check dated 2026-08-06T20:15:53.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page now includes a new revision line: Revision: v3.6.4, and the previous Revision: v3.6.3 line was removed. This marks a new page revision rather than any substantive content change.
    Difference
    0.0%
    Check dated 2026-07-23T13:16:39.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.1 to v3.6.3, indicating a newer version of the page or associated documentation.
    Difference
    0.0%
    Check dated 2026-07-02T03:24:57.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.0 to v3.6.1, signaling a new backend/software release. The update appears to be metadata-related and does not modify the study content.
    Difference
    0.0%
    Check dated 2026-06-25T00:33:58.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Enrollment status on the EV-302 study page has been updated to 'No longer looking for participants', indicating recruitment for this trial is closed. This change communicates to potential participants and researchers that no new enrollments are being accepted for this study.
    Difference
    0.1%
    Check dated 2026-06-10T19:51:48.000Z thumbnail image

Stay in the know with updates to Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page.